Back to companies

Inovio Pharmaceuticals Inc: Overview

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. Its product pipeline includes VGX-3100 for the treatment of cervical HSIL, vulvar HSIL, anal HSIL; INO-5401 for glioblastoma; INO-3107 for recurrent respiratory papillomatosis (RRP); and INO-5151 for prostate cancer. The company is also engaged in development programs in partnership with several companies and government bodies to develop therapeutics for infectious diseases such as HIV, Ebola, Zika virus, Middle East respiratory syndrome (MERS), Lassa fever and COVID-19. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Headquarters United States of America

Address 6769 Mesa Ridge Rd., San Diego, California, 92121


Telephone 1 858 4103134

No of Employees 317

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange INO (NASD)

Revenue (2020) $1.8M -76.1% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -82.5% (2020 vs 2019)

Market Cap* $540.5M

Net Profit Margin (2020) XXX -662.0% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Inovio Pharmaceuticals Inc

100+

Catalyst Calendar

Proactively evaluate Inovio Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

70+

Clinical Trials

Determine Inovio Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

70+

Pipeline Drugs

Identify which of Inovio Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Inovio Pharmaceuticals Inc’s relevant decision makers and contact details.

18+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

13+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

70+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

30+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

12+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

2

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Pipeline products: dMAb
COVID-19: SynCon
INO-4800 Cellectra
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2021 Regulatory Approval In November, the company received approval from the Drug Controller General of India for Phase III trial of the Covid-19 vaccine, INO-4800, in India.
2021 Contracts/Agreements In November, the company entered into a collaboration with Geneva University Hospitals and GuardRX for the clinical trial of its Ebola DNA vaccine candidate, INO-4201.
2021 Contracts/Agreements In October, the company entered into a memorandum of understanding with Colombia's Ministry of Health and Social Protection to combat Coronavirus disease.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Inovio Pharmaceuticals Inc Pfizer Inc Merck & Co Inc GSK plc Sanofi
Headquarters United States of America United States of America United States of America United Kingdom France
City San Diego New York Kenilworth Brentford Paris
State/Province California New York New Jersey - -
No. of Employees 317 79,000 68,000 90,096 95,442
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Simon X. Benito Chairman Executive Board 2019 77
Jacqueline E. Shea, Ph.D. Chief Executive Officer; President Senior Management 2022 -
Peter D. Kies Chief Financial Officer Senior Management 2002 58
Michael Sumner Chief Medical Officer Senior Management 2022 -
Laurent Humeau, Ph.D. Chief Scientific Officer Senior Management 2019 55
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer